Director/PDMR Shareholding

GW Pharmaceuticals PLC Director/PDMR Shareholding

GW Pharmaceuticals PLC

13 June 2012

GW Pharmaceuticals PLC

GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")

NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

Porton Down, UK, 13 June 2012: GW Pharmaceuticals (AIM: GWP) hereby provides notification that the Company was notified on 12 June 2012 that, on 11 June 2012, Dr Geoffrey Guy, a Director and Executive Chairman of the Company, transferred 5,450 0.1 pence ordinary shares of GW Pharmaceuticals plc into his personal pension scheme.

This transaction, representing less than 0.1% of the Company's current issued share capital, was completed when the market price was 81.25 pence per share.

Following this notification Dr Guy's beneficial interest in 17,187,654 GW Pharmaceuticals plc ordinary shares of 0.1 pence each, representing 12.9% of the Company's current issued share capital, remains unchanged.

The total number of shares outstanding in the Company is 133,345,354 ordinary shares of 0.1 pence each.

Enquiries:

GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000

Adam George, Company Secretary

Peel Hunt LLP (Nominated Adviser) Tel: +44 (0)207 418 8900

James Steel/Vijay Barathan